Hypercalcaemia of malignancy and Rectal haemorrhage

Summary:

Rectal haemorrhage is found among people with Hypercalcaemia of malignancy, especially for people who are female, 60+ old.

The study analyzes which people have Rectal haemorrhage with Hypercalcaemia of malignancy. It is created by eHealthMe based on reports of 68 people who have Hypercalcaemia of malignancy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypercalcaemia of malignancy?

Hypercalcaemia of malignancy (elevated calcium (ca+) level in the blood with cancer) is found to be associated with 88 drugs and 111 conditions by eHealthMe. Check the latest studies of Hypercalcaemia of malignancy.

What is Rectal haemorrhage?

Rectal haemorrhage (bleeding from anus) is found to be associated with 1,727 drugs and 1,597 conditions by eHealthMe. Check the latest studies of Rectal haemorrhage.

On Jul, 26, 2026

68 people who have Hypercalcaemia Of Malignancy and Rectal Haemorrhage are studied.

Would you have Rectal haemorrhage when you have Hypercalcaemia of malignancy?

Gender of people who have Hypercalcaemia Of Malignancy and experienced Rectal Haemorrhage *:

female: 94.83 %
male: 5.17 %

Age of people who have Hypercalcaemia Of Malignancy and experienced Rectal Haemorrhage *:

Common co-existing conditions for these people *:

Blood Potassium Decreased: 52 people, 76.47%
Breast Cancer Metastatic: 52 people, 76.47%
Gastrointestinal Motility Disorder (abnormal intestinal contractions): 52 people, 76.47%
Blood Phosphorus Decreased: 51 people, 75.00%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 48 people, 70.59%
Urinary Tract Infection: 47 people, 69.12%
High Blood Pressure: 47 people, 69.12%
Glossodynia (a burning or painful sensation in the tongue): 45 people, 66.18%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 43 people, 63.24%
Rash Pruritic (redness with itching): 39 people, 57.35%

Common drugs taken by these people *:

Zopiclone: 52 people, 76.47%
Zoledronic Acid: 52 people, 76.47%
Metformin: 52 people, 76.47%
Rivaroxaban: 51 people, 75.00%
Sitagliptin: 51 people, 75.00%
Magnesium Glycerophosphate: 48 people, 70.59%
Amlodipine: 47 people, 69.12%
Gliclazide: 45 people, 66.18%
Linagliptin: 45 people, 66.18%
Taxotere: 43 people, 63.24%

Common symptoms for these people *:

Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 64 people, 94.12%
Weight Decreased: 62 people, 91.18%
Back Pain: 60 people, 88.24%
Nausea And Vomiting: 53 people, 77.94%
Gallstones (stone formation by bile component): 53 people, 77.94%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 52 people, 76.47%
Diarrhea: 52 people, 76.47%
Rash Pruritic (redness with itching): 47 people, 69.12%
Urinary Tract Infection: 41 people, 60.29%
Disease Progression: 33 people, 48.53%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Rectal haemorrhage?

- Check whether Rectal haemorrhage is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Hypercalcaemia of malignancy (1,132 reports)
Rectal haemorrhage (56,949 reports)

All the drugs that are associated with Rectal haemorrhage:

Rectal haemorrhage (1,727 drugs)

All the conditions that are associated with Rectal haemorrhage:

Rectal haemorrhage (1,597 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Rectal haemorrhage and Hypercalcaemia of malignancy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.